T.E. Redelmeier
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Lipid Membrane Structure and Behavior 7
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 2
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Pieter R. Cullis (7 shared papers)Paul Richard Harrigan (4 shared papers)Marcel B. Bally (4 shared papers)Sandra L. Schmid (2 shared papers)Thomas D. Madden (3 shared papers)Michael J. Hope (4 shared papers)Simon J. Eastman (5 shared papers)Lawrence D. Mayer (2 shared papers)
- Journals
- Chemistry and Physics of Lipids (2 papers)Biochemistry (2 papers)Biophysical Journal (2 papers)Journal of Pharmaceutical Sciences (2 papers)Molecular Therapy (1 paper)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
T.E. Redelmeier
20 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Biomaterials 399
- Pharmaceutical Science 133
- Cell Biology 223
- Molecular Biology 875
- Oncology 141
Countries citing papers authored by T.E. Redelmeier
This map shows the geographic impact of T.E. Redelmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.E. Redelmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.E. Redelmeier more than expected).
Fields of papers citing papers by T.E. Redelmeier
This network shows the impact of papers produced by T.E. Redelmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.E. Redelmeier. The network helps show where T.E. Redelmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside T.E. Redelmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 220 | |
| 2 | 1993 | 169 | |
| 3 | 1993 | 160 | |
| 4 | Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models. | 2000 | 147 |
| 5 | 1989 | 107 | |
| 6 | 2019 | 70 | |
| 7 | 1993 | 65 | |
| 8 | 2014 | 62 | |
| 9 | 1990 | 50 | |
| 10 | 2013 | 49 | |
| 11 | 1988 | 44 | |
| 12 | 2016 | 41 | |
| 13 | 1989 | 39 | |
| 14 | 1992 | 30 | |
| 15 | 2016 | 24 | |
| 16 | 2015 | 9 | |
| 17 | 2015 | 6 | |
| 18 | 2014 | 4 | |
| 19 | 2015 | 3 | |
| 20 | 2015 | 1 |
About T.E. Redelmeier
T.E. Redelmeier is a scholar working on Molecular Biology, Biomaterials, Cell Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (7 papers), Nanoparticle-Based Drug Delivery (4 papers), Molecular Sensors and Ion Detection (2 papers), Cellular transport and secretion (2 papers), RNA Interference and Gene Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Supramolecular Chemistry and Complexes (1 paper). The work is most often cited by research in Biomaterials (399 citations), Pharmaceutical Science (133 citations), Cell Biology (223 citations), Molecular Biology (875 citations) and Oncology (141 citations). T.E. Redelmeier has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Pieter R. Cullis, Paul Richard Harrigan, Marcel B. Bally, Sandra L. Schmid, Thomas D. Madden, Michael J. Hope, Simon J. Eastman, Lawrence D. Mayer, Helen Loughrey and Kim F. Wong. Their work appears in journals such as Chemistry and Physics of Lipids, Biochemistry, Biophysical Journal, Journal of Pharmaceutical Sciences and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.